Special Issues
International Journal of Molecular Sciences publishes Special Issues to create collections of papers on specific topics, with the aim of building a community of authors and readers to discuss the latest research and develop new ideas and research directions. Special Issues are led by Guest Editors, who are experts on the topic and all Special Issue submissions follow MDPI's standard editorial process.
The journal’s Editor-in-Chief and/or designated Editorial Board Member will oversee Guest Editor appointments and Special Issue proposals, checking their content for relevance and ensuring the suitability of the material for the journal. The papers published in a Special Issue will be collected and displayed on a dedicated page of the journal’s website. Further information on MDPI's Special Issue polices and Guest Editor responsibilities can be found here. For any inquiries related to a Special Issue, please contact the Editorial Office.
Spike Protein Receptor
Deadline: 15 November 2026
Molecular Research on Cancer Stem Cells
Deadline: 20 November 2026
Medicinal Plants and Natural Compounds in Health and Disease: Progresses, Challenges, Opportunities, 2nd Edition
Deadline: 20 November 2026
Unraveling the Molecular Mechanisms of Neurodegeneration
Deadline: 20 November 2026
Exploring Novel Molecular, Metabolic and Cellular Mechanisms for Developing New Therapeutic Targets Against Childhood Cancers, 2nd Edition
Deadline: 20 November 2026
Molecular Mechanisms and Emerging Therapies in Neurovascular Disease
Deadline: 20 November 2026
Peripheral Neuropathies: Molecular Research and Novel Therapy—2nd Edition
Deadline: 20 November 2026
Advances in Sepsis: Molecular and Biochemical Perspectives
Deadline: 20 November 2026
Advanced Research on Cancer Stem Cells
Deadline: 20 November 2026
Bioactive Compounds in Foods: From Structural Profiling to Bioavailability and Health Benefits
Deadline: 20 November 2026
Biomolecular Condensates and Their Role in Cellular Organization and Disease
Deadline: 20 November 2026
Advancing Precision Medicine in Urological Cancers: Integrating Multi-Omics and Optimizing Therapeutic Approaches
Deadline: 20 November 2026
of 253

